These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 15105283

  • 1. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE.
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [Abstract] [Full Text] [Related]

  • 2. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL, Tse GH, Fox KA, Ludlam CA, Megson I, Newby DE.
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 4. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Witherow FN, Helmy A, Webb DJ, Fox KA, Newby DE.
    Circulation; 2001 Oct 30; 104(18):2177-81. PubMed ID: 11684627
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 30; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
    Ritter JM, Cockcroft JR, Sciberras DG, Goldberg MR.
    J Hypertens Suppl; 1993 Apr 30; 11(3):S59-61. PubMed ID: 8391072
    [Abstract] [Full Text] [Related]

  • 7. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP, Vittorio TJ, Dimayuga CA, Homma S, Rizkala A, Le Jemtel TH, Katz SD.
    Am J Cardiol; 2004 Dec 15; 94(12):1501-5. PubMed ID: 15589004
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP, Rumley A, Lowe GD, McMurray JJ.
    Thromb Haemost; 2001 Dec 15; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract] [Full Text] [Related]

  • 9. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
    Davie AP, Dargie HJ, McMurray JJ.
    Circulation; 1999 Jul 20; 100(3):268-73. PubMed ID: 10411851
    [Abstract] [Full Text] [Related]

  • 10. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB, Qiu CS, Hess P, Clozel JP, Clozel M.
    Acta Pharmacol Sin; 2001 Jun 20; 22(6):541-8. PubMed ID: 11747762
    [Abstract] [Full Text] [Related]

  • 11. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, Newby DE.
    J Cardiovasc Pharmacol; 2008 Nov 20; 52(5):438-44. PubMed ID: 19033823
    [Abstract] [Full Text] [Related]

  • 12. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
    Juhlin T, Erhardt LR, Ottosson H, Jönsson BA, Höglund P.
    Eur J Heart Fail; 2007 Feb 20; 9(2):191-6. PubMed ID: 16859993
    [Abstract] [Full Text] [Related]

  • 13. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb 20; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 14. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA, Berezin AE.
    Ter Arkh; 2002 Feb 20; 74(1):52-5. PubMed ID: 11878061
    [Abstract] [Full Text] [Related]

  • 15. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
    Binkley PF, Nunziata E, Haas GJ, Starling RC, Leier CV, Cody RJ.
    Am Heart J; 2000 Jul 20; 140(1):34-42. PubMed ID: 10874261
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR, de Mey C, Wroblewski JM, Li Q, Schroeter V, Belz GG.
    Clin Pharmacol Ther; 1996 Jan 20; 59(1):72-82. PubMed ID: 8549037
    [Abstract] [Full Text] [Related]

  • 17. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M, Lauri G, Melzi G, Cattadori G, Agostoni P.
    Cardiologia; 1996 Jun 20; 41(6):527-33. PubMed ID: 8766415
    [Abstract] [Full Text] [Related]

  • 18. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 20; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
    Dickstein K, Gottlieb S, Fleck E, Kostis J, Levine B, DeKock M, LeJemtel T.
    J Hypertens Suppl; 1994 Jul 20; 12(2):S31-5. PubMed ID: 7965263
    [Abstract] [Full Text] [Related]

  • 20. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
    Nielsen S, Dollerup J, Nielsen B, Jensen HA, Mogensen CE.
    Nephrol Dial Transplant; 1997 Jul 20; 12 Suppl 2():19-23. PubMed ID: 9269694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.